Navigator

      Support By : Li-lab

Drugs And Genes
Negative Drug Target Genes
GENE_SYMBOL DRUG_NAME Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) Potency (nM) AC50 (nM) Datasource
KCNH2 6-Chloro-5-{4-[3-(dimethylamino)propoxy]-2,6-difluorophenyl}-2-(1H-imidazol-1-yl)-N-(2,2,2-trifluoroethyl)pyrimidin-4-amine NA 239000|310000 NA NA NA NA BindingDB
KCNH2 7-(3-((2-Cyanoethylamino)methyl)-3-ethylazetidin-1-yl)-1-cyclopropyl-6-fluoro-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 150000 NA NA NA NA NA TTD
KCNH2 cis-4-[3-(4-Pyrrolidin-1-ylmethyl-phenyl)-cyclobutylmethyl]-morpholine NA 300000 NA NA NA NA BindingDB|TTD
KCNH2 6-[(3R)-3-[(1S)-2-cyano-1-(methylamino)ethyl]pyrrolidin-1-yl]-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid 150000 NA NA NA NA NA TTD
KCNH2 Gosogliptin NA 126000 NA NA NA NA BindingDB|PubChem|TTD
KCNH2 2-(4-((6,7-dimethoxyquinazolin-4-yl)oxy)phenyl)-N-(1-isopropyl-1H-pyrazol-4-yl)acetamide NA 137000 NA NA NA NA BindingDB|TTD
KCNH2 N-{6-[(1S)-1-(4-Fluorophenyl)-2,2-di(pyridin-3-yl)ethyl]pyridin-2-yl}methanesulfonamide NA 110000 NA NA NA NA BindingDB|TTD
KCNH2 Viquidacin NA 124000 NA NA NA NA BindingDB
KCNH2 Cbs-3595 NA 213000 NA NA NA NA BindingDB|TTD
KCNH2 6-((1H-1,2,4-triazol-1-yl)methyl)-3-(5-(3-(2-methoxyethoxy)-prop-1-ynyl)thiophen-3-yl)-1,4-dihydroindeno[1,2-c]pyrazole NA 150000 NA NA NA NA TTD
KCNH2 Levobupivacaine Hydrochloride NA 278000|1013000 NA NA NA NA PubChem
KCNH2 US10207991, Ex. Cpd. No. 78 NA 110000 NA NA NA NA BindingDB
KCNH2 4,5-Dichloro-2-[9-[[2-(2-methoxyphenoxy)phenyl]methyl]-3,9-diazaspiro[5.5]undecane-3-carbonyl]benzoic acid NA 954992586 NA NA NA NA BindingDB|TTD
KCNH2 3-[[4-(3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carbonyloxymethyl)piperidin-1-yl]methyl]cyclopentane-1-carboxylic acid NA 209000 NA NA NA NA BindingDB|TTD
KCNH2 2-[[[4-[(1R)-1-amino-2-(7-fluoro-4-methyl-2-oxoquinolin-1-yl)ethyl]cyclohexyl]amino]methyl]-8H-pyrimido[5,4-b][1,4]oxazin-7-one NA 333000 NA NA NA NA TTD
KCNH2 2-[[[4-[(1R)-1-amino-2-(6-fluoro-7-methoxy-2-oxoquinoxalin-1-yl)ethyl]cyclohexyl]amino]methyl]-8H-pyrimido[5,4-b][1,4]oxazin-7-one NA 333000 NA NA NA NA TTD
KCNH2 6-[[[1-[[(3S)-5-fluoro-3-hydroxy-11-oxo-1,7-diazatricyclo[6.3.1.04,12]dodeca-4(12),5,7,9-tetraen-3-yl]methyl]-2-oxabicyclo[2.2.2]octan-4-yl]amino]methyl]-4H-pyrido[3,2-b][1,4]oxazin-3-one NA 394000 NA NA NA NA BindingDB|TTD
KCNH2 7-fluoro-6-[[[1-[[(3R)-5-fluoro-3-hydroxy-11-oxo-1,7-diazatricyclo[6.3.1.04,12]dodeca-4(12),5,7,9-tetraen-3-yl]methyl]-2-oxabicyclo[2.2.2]octan-4-yl]amino]methyl]-4H-pyrido[3,2-b][1,4]oxazin-3-one NA 333000 NA NA NA NA BindingDB
KCNH2 7-chloro-6-[[[1-[[(3R)-5-fluoro-3-hydroxy-11-oxo-1,7-diazatricyclo[6.3.1.04,12]dodeca-4(12),5,7,9-tetraen-3-yl]methyl]-2-oxabicyclo[2.2.2]octan-4-yl]amino]methyl]-4H-pyrido[3,2-b][1,4]oxazin-3-one NA 126000 NA NA NA NA BindingDB|TTD
KCNH2 (3R)-3-[[4-(2,3-dihydro-[1,4]dioxino[2,3-c]pyridin-7-ylmethylamino)-2-oxabicyclo[2.2.2]octan-1-yl]methyl]-5-fluoro-3-hydroxy-1,7-diazatricyclo[6.3.1.04,12]dodeca-4(12),5,7,9-tetraen-11-one NA 764000 NA NA NA NA BindingDB